CLINICAL_TRIALS
trial_result
· 2007-09-24
Clinical Trial Update: Gabapentin for the Treatment of Neuroleptic-Induced Tremor [Phase 3]
Summary
Phase 3 clinical trial evaluating gabapentin for neuroleptic-induced tremor has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Minneapolis Veterans Affairs Medical Center | Conditions: Neuroleptic-Induced Tremor | Phase 3 | Status: TERMINATED